PPAR Research

/ Table of Contents: 2011

Table of Contents

Table of Contents: 2011

PPAR Research -
Special Issue
Volume 2011
- Article ID 926438
- Research Article

Rosiglitazone and Pioglitazone Alter Aromatase Kinetic Properties in Human Granulosa Cells

Takako Araki | Miroslava Varadinova | ... | Donna Seto-Young

PPAR Research -
Special Issue
Volume 2011
- Article ID 171765
- Research Article

PPAR Promotes Growth and Invasion of Thyroid Cancer Cells

William M. Wood | Vibha Sharma | ... | Bryan R. Haugen

PPAR Research -
Special Issue
Volume 2011
- Article ID 840194
- Research Article

Involvement of the Retinoid X Receptor Ligand in the Anti-Inflammatory Effect Induced by Peroxisome Proliferator-Activated Receptor Agonist In Vivo

Atsuki Yamamoto | Hiroki Kakuta | ... | Yukio Sugimoto

PPAR Research -
Special Issue
Volume 2011
- Article ID 502631
- Research Article

Peroxisome Proliferator-Activated Receptor- Activation Decreases Mean Arterial Pressure, Plasma Interleukin-6, and COX-2 While Increasing Renal CYP4A Expression in an Acute Model of DOCA-Salt Hypertension

Dexter L. Lee | Justin L. Wilson | ... | Ahmed El-Marakby

PPAR Research -
Special Issue
Volume 2011
- Article ID 436358
- Research Article

Skeletal Effects of the Saturated 3-Thia Fatty Acid Tetradecylthioacetic Acid in Rats

Astrid Kamilla Stunes | Irene Westbroek | ... | Unni Syversen

PPAR Research -
Special Issue
Volume 2011
- Article ID 291656
- Research Article

Rosiglitazone Restores Endothelial Dysfunction in a Rat Model of Metabolic Syndrome through PPAR- and PPAR-Dependent Phosphorylation of Akt and eNOS

Zhigang Zhao | Zhidan Luo | ... | Zhiming Zhu

PPAR Research -
Special Issue
Volume 2011
- Article ID 523520
- Research Article

PPAR-α Agonist Fenofibrate Upregulates Tetrahydrobiopterin Level through Increasing the Expression of Guanosine 5′-Triphosphate Cyclohydrolase-I in Human Umbilical Vein Endothelial Cells

Jinbo Liu | Changlin Lu | ... | Guang Wang

PPAR Research -
Special Issue
Volume 2011
- Article ID 164925
- Research Article

Upregulation of Scavenger Receptor BI by Hepatic Nuclear Factor 4α through a Peroxisome Proliferator-Activated Receptor γ-Dependent Mechanism in Liver

Yi Zhang | Chen Shen | ... | Yi Zhu

PPAR Research -
Special Issue
Volume 2011
- Article ID 867180
- Review Article

Thiazolidinediones on PPARγ: The Roles in Bone Remodeling

Wei Wei | Yihong Wan

PPAR Research -
Special Issue
Volume 2011
- Article ID 373560
- Review Article

Neuroprotective Mechanisms of PPARδ: Modulation of Oxidative Stress and Inflammatory Processes

Caroline I. Schnegg | Mike E. Robbins

PPAR Research -
Special Issue
Volume 2011
- Article ID 753917
- Research Article

Atherogenic ω-6 Lipids Modulate PPAR- EGR-1 Crosstalk in Vascular Cells

Jia Fei | Carla Cook | ... | Nalini Santanam

PPAR Research -
Special Issue
Volume 2011
- Article ID 179454
- Research Article

Rosiglitazone Induces Mitochondrial Biogenesis in Differentiated Murine 3T3-L1 and C3H/10T1/2 Adipocytes

James X. Rong | Jean-Louis D. Klein | ... | Jay C. Strum

PPAR Research -
Special Issue
Volume 2011
- Article ID 742785
- Review Article

A Retrospective on Nuclear Receptor Regulation of Inflammation: Lessons from GR and PPARs

Min-Dian Li | Xiaoyong Yang

PPAR Research -
Special Issue
Volume 2011
- Article ID 256186
- Research Article

Consequences of PPAR_α Invalidation on Glutathione Synthesis: Interactions with Dietary Fatty Acids

Najoua Guelzim | Jean-François Huneau | ... | Dominique Hermier

PPAR Research -
Special Issue
Volume 2011
- Article ID 372854
- Research Article

Cardiomyocyte-Restricted Deletion of PPARβ/δ in PPARα-Null Mice Causes Impaired Mitochondrial Biogenesis and Defense, but No Further Depression of Myocardial Fatty Acid Oxidation

Jian Liu | Peiyong Wang | ... | Qinglin Yang

Evaluate your manuscript with the free Manuscript Language Checker

Author guidelines

Editorial board

Databases and indexing

We have begun to integrate the 200+ Hindawi journals into Wiley’s journal portfolio. You can find out more about how this benefits our journal communities on our FAQ.